NIH-funded research R21 grant

Exploring how FLASH-Radiotherapy affects tumors and healthy tissue

Official title: Investigating the Effect of FLASH-Radiotherapy on Tumor and Normal Tissue

Funded at University of Tx Md Anderson Can Ctr · NIH-10834212 · Data updated 2026-11-12

This study is looking at a new type of radiation therapy called FLASH-Radiotherapy to see if it can better treat head and neck cancer while causing fewer side effects, so patients might have a safer and more effective treatment option.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2024
Award (this year)$179,870
NIH project number5R21CA273845-02
Project IDNIH-10834212 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with head and neck squamous cell carcinoma who are seeking innovative treatment options.

Less likely to help

Patients with other types of cancers or those not diagnosed with head and neck squamous cell carcinoma may not benefit from this research.

What this research studies

This research investigates a new form of radiation therapy called FLASH-Radiotherapy, which delivers high doses of radiation to tumors in a very short time frame. The goal is to determine how this method impacts head and neck squamous cell carcinoma (HNSCC) and surrounding healthy tissues. By comparing FLASH-Radiotherapy to traditional radiation methods, the researchers aim to find ways to improve tumor control while reducing side effects. Patients may benefit from a more effective and less harmful treatment option if the research proves successful.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for head and neck cancer with fewer side effects.

How similar studies have gone: While FLASH-Radiotherapy is a novel approach, preliminary studies have shown promising results in reducing damage to healthy tissues compared to traditional methods.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Frank, Steven Jay — University of Tx Md Anderson Can Ctr
  • Study coordinator: Frank, Steven Jay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.